|
Bliss GVS Pharma Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
1648.40 Cr.
|
P/BV
|
1.63
|
Book Value (Rs.)
|
95.74
|
|
52 Week High/Low (Rs.)
|
186/103
|
FV/ML
|
1/1
|
P/E(X)
|
19.55
|
|
Bookclosure
|
25/07/2024
|
EPS (Rs.)
|
7.99
|
Div Yield (%)
|
0.32
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 8.02 | 7.23 | 6.83 | 1.46 | 6.64 |
| Diluted EPS (Rs.) | 7.95 | 7.11 | 6.72 | 1.43 | 6.49 |
| Cash EPS (Rs.) | 11.36 | 10.31 | 9.16 | 3.90 | 8.84 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 99.68 | 95.80 | 88.08 | 81.64 | 80.27 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 99.68 | 95.80 | 88.08 | 81.64 | 80.27 |
| Revenue From Operations / Share (Rs.) | 76.85 | 73.57 | 72.16 | 72.09 | 55.96 |
| PBDIT / Share (Rs.) | 15.49 | 17.13 | 12.97 | 14.45 | 12.30 |
| PBIT / Share (Rs.) | 12.69 | 14.61 | 11.18 | 12.78 | 10.63 |
| PBT / Share (Rs.) | 11.92 | 11.16 | 10.18 | 5.22 | 10.10 |
| Net Profit / Share (Rs.) | 8.57 | 7.79 | 7.37 | 2.23 | 7.17 |
| NP After MI And SOA / Share (Rs.) | 8.00 | 7.21 | 6.80 | 1.45 | 6.64 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 20.15 | 23.28 | 17.97 | 20.04 | 21.98 |
| PBIT Margin (%) | 16.51 | 19.86 | 15.49 | 17.72 | 18.99 |
| PBT Margin (%) | 15.51 | 15.17 | 14.11 | 7.24 | 18.03 |
| Net Profit Margin (%) | 11.14 | 10.59 | 10.20 | 3.09 | 12.81 |
| NP After MI And SOA Margin (%) | 10.41 | 9.79 | 9.42 | 2.01 | 11.86 |
| Return on Networth / Equity (%) | 8.02 | 7.80 | 8.01 | 1.83 | 8.47 |
| Return on Capital Employeed (%) | 11.84 | 14.51 | 12.08 | 15.13 | 12.55 |
| Return On Assets (%) | 6.48 | 6.21 | 6.12 | 1.35 | 6.36 |
| Long Term Debt / Equity (X) | 0.01 | 0.03 | 0.04 | 0.02 | 0.04 |
| Total Debt / Equity (X) | 0.06 | 0.09 | 0.11 | 0.12 | 0.12 |
| Asset Turnover Ratio (%) | 0.64 | 0.64 | 0.53 | 0.59 | 0.47 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 4.81 | 5.08 | 3.61 | 3.33 | 3.76 |
| Quick Ratio (X) | 4.08 | 4.34 | 3.08 | 2.80 | 3.27 |
| Inventory Turnover Ratio (X) | 3.05 | 3.06 | 2.96 | 3.71 | 2.73 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 6.90 | 7.32 | 34.41 | 7.52 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 5.11 | 5.79 | 15.98 | 6.01 |
| Earning Retention Ratio (%) | 0.00 | 93.10 | 92.68 | 65.59 | 92.48 |
| Cash Earning Retention Ratio (%) | 0.00 | 94.89 | 94.21 | 84.02 | 93.99 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 20.10 | 25.95 | 13.04 | 31.60 | 23.01 |
| Interest Coverage Ratio (Post Tax) (%) | 12.12 | 17.03 | 8.40 | 21.40 | 14.42 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 1137.76 | 1087.33 | 770.70 | 752.99 | 990.81 |
| EV / Net Operating Revenue (X) | 1.41 | 1.41 | 1.03 | 1.01 | 1.72 |
| EV / EBITDA (X) | 6.97 | 6.06 | 5.70 | 5.03 | 7.81 |
| MarketCap / Net Operating Revenue (X) | 1.53 | 1.53 | 0.98 | 1.07 | 1.76 |
| Retention Ratios (%) | 0.00 | 93.09 | 92.67 | 65.58 | 92.47 |
| Price / BV (X) | 1.18 | 1.22 | 0.83 | 0.97 | 1.26 |
| Price / Net Operating Revenue (X) | 1.53 | 1.53 | 0.98 | 1.07 | 1.76 |
| EarningsYield | 0.06 | 0.06 | 0.09 | 0.01 | 0.06 |
